Caloric restriction attenuates the age-associated increase of adipose-derived stem cells but further reduces their proliferative capacity.

Age
Eric G SchmuckKurt W Saupe

Abstract

White adipose tissue is a promising source of mesenchymal stem cells. Currently, little is known about the effect of age and caloric restriction (CR) on adipose-derived stem cells (ASC). This is important for three reasons: firstly, age and CR cause extensive remodeling of WAT; it is currently unknown how this remodeling affects the resident stem cell population. Secondly, stem cell senescence has been theorized as one of the causes of aging and could reduce the utility of a stem cell as a reagent. Thirdly, the mechanism by which CR extends lifespan is currently not known, one theory postulates that CR maintains the resident stem cell population in youthful "fit" state. For the purpose of this study, we define ASC as lineage negative (lin(-))/CD34(+(low))/CD31(-). We show that aging increases the abundance of ASC and the expression of Cdkn2a 9.8-fold and Isl1 60.6-fold. This would suggest that aging causes an accumulation of non-replicative ASC. CR reduced the percentage of ASC in the lin(-) SVF while also reducing colony forming ability. Therefore, CR appears to have anti-proliferative effects on ASC that may be advantageous from the perspective of cancer, but our data raises the possibility that it may be disadvantageous for ...Continue Reading

References

Feb 1, 1990·The American Journal of Physiology·J L KirklandW S Gillon
Sep 26, 1995·Proceedings of the National Academy of Sciences of the United States of America·G P DimriO Pereira-Smith
Jan 1, 1994·Journal of Gerontology·J L KirklandW S Gillon
Feb 24, 2001·Lancet·P MenaschéJ P Marolleau
Sep 27, 2001·Journal of Cellular Physiology·S GronthosJ M Gimble
Oct 30, 2001·The Proceedings of the Nutrition Society·P Trayhurn, J H Beattie
Nov 2, 2001·Nature·T ReyaI L Weissman
Nov 14, 2002·Cell Cycle·Mikhail V Blagosklonny, Arthur B Pardee
Dec 12, 2002·Molecular Biology of the Cell·Patricia A ZukMarc H Hedrick
Dec 28, 2002·Diabetes·Alexandra E ButlerPeter C Butler
Jan 23, 2004·Nature Reviews. Cancer·Ricardo PardalSean J Morrison
Dec 23, 2004·American Journal of Physiology. Endocrinology and Metabolism·Elaine A HsiehMarc K Hellerstein
Jan 11, 2005·Cardiovascular Research·Ofelia María Martínez-EstradaSenén Vilaró
Apr 15, 2005·Nature·Tannishtha Reya, Hans Clevers
Jan 18, 2006·Stem Cells·Kevin McIntoshJeffrey M Gimble
Feb 8, 2006·Biochemical and Biophysical Research Communications·Katharina TimperHenryk Zulewski
May 12, 2006·Developmental Biology·Lizhu LinSylvia Evans
May 23, 2006·Biochemical and Biophysical Research Communications·Michael EberhardtHenryk Zulewski
May 31, 2006·Journal of Atherosclerosis and Thrombosis·Hironori NakagamiYasufumi Kaneda
Sep 8, 2006·Nature·Janakiraman KrishnamurthyNorman E Sharpless
May 15, 2007·Circulation Research·Jeffrey M GimbleBruce A Bunnell
Aug 25, 2007·Nature Reviews. Molecular Cell Biology·Norman E Sharpless, Ronald A DePinho
Sep 20, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Dayong WuSimin Nikbin Meydani
Apr 1, 2008·Annual Review of Biochemistry·William Mair, Andrew Dillin
Oct 7, 2008·Cell·Matthew S RodehefferJeffrey M Friedman
Dec 17, 2008·Toxicologic Pathology·Rozalyn M AndersonRichard Weindruch
Dec 17, 2008·The Journal of Pathology·M R Alison, S Islam
Mar 25, 2009·Journal of Tissue Engineering and Regenerative Medicine·Min ZhuPatricia Zuk
Jul 7, 2009·Ageing Research Reviews·Jennifer L KukRobert Ross
Jul 25, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Rosalinda MadonnaRaffaele De Caterina
Jan 29, 2010·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Mark J CartwrightJames L Kirkland

❮ Previous
Next ❯

Citations

Jan 24, 2012·Stem Cell Research·Eckhard U AltReza Izadpanah
Oct 30, 2015·International Journal of Molecular Sciences·Maximina H Yun
Nov 12, 2013·Experimental Gerontology·Gianluigi MazzoccoliManlio Vinciguerra

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.